Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.

O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D

Open source

DOI
10.7759/cureus.78171
Published
2025 Jan
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.78171,
  title = {Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.},
  author = {O'Connor S and Godfrey K and Reed S and Peill J and Rohani-Shukla C and Healy M and Robbins T and Frota Lisboa Pereira de Souza A and Tyacke R and Papasyrou M and Stenbæk D and Castro-Rodrigues P and Chiera M and Lee H and Martell J and Carhart-Harris R and Pellegrini L and Fineberg NA and Nutt D and Erritzoe D},
  year = {2025},
  journal = {Cureus},
  doi = {10.7759/cureus.78171},
  url = {https://doi.org/10.7759/cureus.78171}
}

RIS

TY  - JOUR
TI  - Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.
AU  - O'Connor S
AU  - Godfrey K
AU  - Reed S
AU  - Peill J
AU  - Rohani-Shukla C
AU  - Healy M
AU  - Robbins T
AU  - Frota Lisboa Pereira de Souza A
AU  - Tyacke R
AU  - Papasyrou M
AU  - Stenbæk D
AU  - Castro-Rodrigues P
AU  - Chiera M
AU  - Lee H
AU  - Martell J
AU  - Carhart-Harris R
AU  - Pellegrini L
AU  - Fineberg NA
AU  - Nutt D
AU  - Erritzoe D
PY  - 2025
JO  - Cureus
DO  - 10.7759/cureus.78171
UR  - https://doi.org/10.7759/cureus.78171
ER  - 

APA

S, O., K, G., S, R., J, P., C, R., M, H., T, R., A, F. L. P. D. S., R, T., M, P., D, S., P, C., M, C., H, L., J, M., R, C., L, P., NA, F., D, N., & D, E. (2025). Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.. Cureus. https://doi.org/10.7759/cureus.78171

Source records